Closing Condition. As a condition precedent to the Closing, the transactions contemplated by this Agreement shall have been approved by (i) a majority of the board of directors of the Company (the “Board”), and (ii) the holders of fifty three percent (53%) of the Company’s Series C Preferred stock and Series C-1 Preferred stock, voting together as a single class.
Appears in 2 contracts
Sources: Note Purchase Agreement (Tetralogic Pharmaceuticals Corp), Note Purchase Agreement (Tetralogic Pharmaceuticals Corp)